{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:23:38Z","timestamp":1791829418547,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jaccao.2023.06.007","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T06:40:40Z","timestamp":1694760040000},"page":"807-818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Gene-Level Analysis of Anthracycline-Induced Cardiomyopathy\u00a0in Cancer Survivors"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8835-8899","authenticated-orcid":false,"given":"Noha","family":"Sharafeldin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4968-7398","authenticated-orcid":false,"given":"Purnima","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Crossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Hageman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Landier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier G.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-0006","authenticated-orcid":false,"given":"Paul W.","family":"Burridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadav","family":"Sapkota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie L.","family":"Robison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Oeffinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saro H.","family":"Armenian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Weisdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1016\/j.jaccao.2023.06.007_bib1","first-page":"1","article-title":"Anthracyclines in the treatment of cancer. An overview","volume":"54","author":"Hortobagyi","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.jaccao.2023.06.007_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline chemotherapy and cardiotoxicity","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jaccao.2023.06.007_bib3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/EDBK_100015","article-title":"Predicting and preventing anthracycline-related cardiotoxicity","volume":"38","author":"Armenian","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.jaccao.2023.06.007_bib5","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cvr\/cvz031","article-title":"Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment","volume":"115","author":"Chow","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jaccao.2023.06.007_bib6","first-page":"539","article-title":"Genetics of anthracycline cardiomyopathy in cancer survivors: JACC: CardioOncology state-of-the-art review","volume":"2","author":"Bhatia","year":"2020","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jaccao.2023.06.007_bib7","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1200\/JCO.2011.34.8987","article-title":"Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group","volume":"30","author":"Blanco","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2015.63.4550","article-title":"CELF4 variant and anthracycline-related cardiomyopathy: a Children's Oncology Group genome-wide association study","volume":"34","author":"Wang","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1200\/JCO.2013.50.3557","article-title":"Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the Children's Oncology Group","volume":"32","author":"Wang","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib10","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S1470-2045(14)70409-7","article-title":"Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"16","author":"Armenian","year":"2015","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.jaccao.2023.06.007_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"Hunt","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib12","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaccao.2023.06.007_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003153","article-title":"GEMINI: integrative exploration of genetic variation and genome annotations","volume":"9","author":"Paila","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaccao.2023.06.007_bib15","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1182\/blood-2004-03-1010","article-title":"Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study","volume":"104","author":"Baker","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2023.06.007_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1096-911X(199907)33:1<60::AID-MPO11>3.0.CO;2-H","article-title":"Marriage in the survivors of childhood cancer: a preliminary description from the Childhood Cancer Survivor Study","volume":"33","author":"Rauck","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib17","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2023.06.007_bib18","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","article-title":"Modifiable risk factors and major cardiac events among adult survivors of childhood cancer","volume":"31","author":"Armstrong","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib19","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gkr917","article-title":"HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants","volume":"40","author":"Ward","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaccao.2023.06.007_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jbmr.4234","article-title":"Genome-wide association studies reveal novel locus with sex-\/therapy-specific fracture risk effects in childhood cancer survivors","volume":"36","author":"Im","year":"2021","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jaccao.2023.06.007_bib21","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.jid.2019.02.029","article-title":"Genome-wide association study in irradiated childhood cancer survivors identifies HTR2A for subsequent basal cell carcinoma","volume":"139","author":"Sapkota","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13073-022-01038-6","article-title":"Genome-wide association studies identify novel genetic loci for epigenetic age acceleration among survivors of childhood cancer","volume":"14","author":"Dong","year":"2022","journal-title":"Genome Med"},{"key":"10.1016\/j.jaccao.2023.06.007_bib23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamaoncol.2018.6634","article-title":"Derivation of anthracycline and anthraquinone equivalence ratios to doxorubicin for late-onset cardiotoxicity","volume":"5","author":"Feijen","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1198\/1061860032238","article-title":"Logic regression","volume":"12","author":"Ruczinski","year":"2003","journal-title":"J\u00a0Comp Graph Stat"},{"key":"10.1016\/j.jaccao.2023.06.007_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/B978-0-12-380862-2.00002-3","article-title":"Logic regression and its extensions","volume":"72","author":"Schwender","year":"2010","journal-title":"Adv Genet"},{"key":"10.1016\/j.jaccao.2023.06.007_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/biostatistics\/kxm024","article-title":"Identification of SNP interactions using logic regression","volume":"9","author":"Schwender","year":"2008","journal-title":"Biostatistics"},{"key":"10.1016\/j.jaccao.2023.06.007_bib27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/ATVBAHA.120.315116","article-title":"P2X7 receptors: an untapped target for the management of cardiovascular disease","volume":"41","author":"Shokoples","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib28","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/pr.113.008003","article-title":"The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease","volume":"66","author":"Bartlett","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jaccao.2023.06.007_bib29","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.2147\/JIR.S356038","article-title":"P2X7 receptor and heart function in a mouse model of systemic inflammation due to high fat diet","volume":"15","author":"Raggi","year":"2022","journal-title":"J\u00a0Inflamm Res"},{"key":"10.1016\/j.jaccao.2023.06.007_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11302-019-09660-7","article-title":"Loss of function mutation in the P2X7, a ligand-gated ion channel gene associated with hypertrophic cardiomyopathy","volume":"15","author":"Biswas","year":"2019","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.jaccao.2023.06.007_bib31","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1038\/emboj.2009.285","article-title":"The kinase TNIK is an essential activator of Wnt target genes","volume":"28","author":"Mahmoudi","year":"2009","journal-title":"EMBO J"},{"key":"10.1016\/j.jaccao.2023.06.007_bib32","doi-asserted-by":"crossref","first-page":"25019","DOI":"10.1074\/jbc.M112.372342","article-title":"Misshapen-like kinase 1 (MINK1) is a novel component of striatin-interacting phosphatase and kinase (STRIPAK) and is required for the completion of cytokinesis","volume":"287","author":"Hyodo","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaccao.2023.06.007_bib33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.biocel.2013.11.021","article-title":"STRIPAK complexes: structure, biological function, and involvement in human diseases","volume":"47","author":"Hwang","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251423","article-title":"Genome-wide association study of vitamin D concentrations and bone mineral density in the African American-Diabetes Heart Study","volume":"16","author":"Palmer","year":"2021","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jaccao.2023.06.007_bib35","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/biom11081101","article-title":"LRRK2 targeting strategies as potential treatment of Parkinson's disease","volume":"11","author":"Wojewska","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jaccao.2023.06.007_bib36","first-page":"177","article-title":"LRRK2 inhibitors and their potential in the treatment of Parkinson's disease: current perspectives","volume":"8","author":"Atashrazm","year":"2016","journal-title":"Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jaccao.2023.06.007_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1146\/annurev.publhealth.012809.103723","article-title":"Genome-wide association studies and beyond","volume":"31","author":"Witte","year":"2010","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.jaccao.2023.06.007_bib38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fphar.2018.00052","article-title":"The P2X7 receptor in inflammatory diseases: angel or demon?","volume":"9","author":"Savio","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCRESAHA.116.309726","article-title":"Purinergic signaling in the cardiovascular system","volume":"120","author":"Burnstock","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jaccao.2023.06.007_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","article-title":"From purines to purinergic signalling: molecular functions and human diseases","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaccao.2023.06.007_bib41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ejhg.2011.245","article-title":"Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women","volume":"20","author":"Gartland","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jaccao.2023.06.007_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037491","article-title":"A\u00a0common missense variant in the ATP receptor P2X7 is associated with reduced risk of cardiovascular events","volume":"7","author":"Gidlof","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaccao.2023.06.007_bib43","doi-asserted-by":"crossref","first-page":"11135","DOI":"10.1074\/jbc.M010353200","article-title":"A\u00a0Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor","volume":"276","author":"Gu","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaccao.2023.06.007_bib44","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1182\/blood-2005-07-2994","article-title":"Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor","volume":"107","author":"Gu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2023.06.007_bib45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4049\/jimmunol.175.1.82","article-title":"A\u00a0His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes","volume":"175","author":"Cabrini","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib46","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1074\/jbc.M507816200","article-title":"A\u00a0Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages","volume":"281","author":"Shemon","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaccao.2023.06.007_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jaccao.2023.06.007_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/187221511794839219","article-title":"Significance of P2X7 receptor variants to human health and disease","volume":"5","author":"Sluyter","year":"2011","journal-title":"Recent Pat DNA Gene Seq"},{"key":"10.1016\/j.jaccao.2023.06.007_bib49","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaccao.2023.06.007_bib50","first-page":"2247","article-title":"Safety and efficacy of an oral inhibitor of the purinergic receptor P2X7 in adult patients with moderately to severely active Crohn's disease: a randomized placebo-controlled, double-blind, phase IIa study","volume":"21","author":"Eser","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaccao.2023.06.007_bib51","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3899\/jrheum.110874","article-title":"Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate","volume":"39","author":"Stock","year":"2012","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib52","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22153","article-title":"Structural basis for subtype-specific inhibition of the P2X7 receptor","volume":"5","author":"Karasawa","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.jaccao.2023.06.007_bib53","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/0269881118800067","article-title":"Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants","volume":"32","author":"Timmers","year":"2018","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib54","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41386-018-0141-6","article-title":"Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia","volume":"43","author":"Bhattacharya","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jaccao.2023.06.007_bib55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/bjd.15364","article-title":"A\u00a0phase I clinical trial demonstrates that nfP2X(7) -targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma","volume":"177","author":"Gilbert","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib56","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.coph.2019.03.001","article-title":"Novel biologics targeting the P2X7 ion channel","volume":"47","author":"Koch-Nolte","year":"2019","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib57","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1200\/JCO.22.01527","article-title":"Genome-wide association study identifies robo2 as a novel susceptibility gene for anthracycline-related cardiomyopathy in childhood cancer survivors","volume":"41","author":"Wang","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2023.06.007_bib58","article-title":"Immunomodulating therapies in acute myocarditis and recurrent\/acute pericarditis","volume":"9","author":"Ammirati","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaccao.2023.06.007_bib59","first-page":"1130","article-title":"Cloning and characterization of porcine NOBOX gene","volume":"25","author":"Li","year":"2009","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"issue":"7","key":"10.1016\/j.jaccao.2023.06.007_bib60","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/metabo10070286","article-title":"Find the needle in the haystack, then find it again: replication and validation in the 'omics era","volume":"10","author":"Perng","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.jaccao.2023.06.007_bib61","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1214\/09-STS290","article-title":"Replication in genome-wide association studies","volume":"24","author":"Kraft","year":"2009","journal-title":"Stat Sci"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087323002375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087323002375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:56:09Z","timestamp":1762973769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087323002375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2666087323002375"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2023.06.007","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene-Level Analysis of Anthracycline-Induced Cardiomyopathy\u00a0in Cancer Survivors","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2023.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}